Windlas Biotech Limited Capital Reinvestment Ratio
Windlas Biotech Limited capital reinvestment ratio. Windlas Biotech Limited (WINDLAS) has a Capital Reinvestment Ratio of 0.77x as of March 2025, meaning it reinvests 1% of its operating cash flow (Rs681.87 Million) in capital expenditures (Rs521.94 Million). Check Windlas Biotech Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Windlas Biotech Limited (2018–2025)
Capital reinvestment ratio of Windlas Biotech Limited from 2018 to 2025. This chart tracks Windlas Biotech Limited's Capital Reinvestment Ratio across 8 annual periods. Also explore WINDLAS net assets growth trend to track the company's year-over-year net asset growth rate.
Windlas Biotech Limited Capital Reinvestment Ratio by Year (2018–2025)
Windlas Biotech Limited capital reinvestment ratio by year from 2018 to 2025. For the full cash flow conversion analysis, see Windlas Biotech Limited (WINDLAS) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.77x | Rs681.87 Million | Rs521.94 Million | ▲ +121.3% |
| 2024 | 0.35x | Rs1.09 Billion | Rs376.84 Million | ▼ -70.3% |
| 2023 | 1.16x | Rs609.65 Million | Rs708.90 Million | ▼ -28.3% |
| 2022 | 1.62x | Rs91.30 Million | Rs148.04 Million | ▲ +217.6% |
| 2021 | 0.51x | Rs114.54 Million | Rs58.47 Million | ▼ -16.6% |
| 2020 | 0.61x | Rs250.06 Million | Rs153.10 Million | ▲ +27.6% |
| 2019 | 0.48x | Rs186.54 Million | Rs89.54 Million | ▼ -44.9% |
| 2018 | 0.87x | Rs295.91 Million | Rs257.82 Million | — |